Jun 28 |
Aethlon Medical, Inc. (NASDAQ:AEMD) Q4 2024 Earnings Call Transcript
|
Jun 27 |
Aethlon Medical, Inc. (AEMD) Q4 2024 Earnings Call Transcript
|
Jun 27 |
Aethlon Medical GAAP EPS of -$4.86 beats by $0.33
|
Jun 27 |
Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update
|
Jun 26 |
Aethlon Medical FY 2024 Earnings Preview
|
Jun 24 |
AEMD: Ethics Committee Approval for Safety, Feasibility, Dose-Finding Trial Important Step in Advancing the Hemopurifier
|
Jun 21 |
Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024
|
Jun 20 |
What's Next in Treatments for Cancer Patients with Solid Tumors?
|
Jun 18 |
Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial
|
Jun 17 |
(AEMD) - Analyzing Aethlon Medical's Short Interest
|